Medical Communications

Showing 15 posts of 6402 posts found.

Sanofi and Glooko partner on ‘connected insulin’ tech

February 24, 2023 Medical Communications

Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …

Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use

February 24, 2023 Medical Communications

US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …

NICE approved BMS’s Opdivo for lung cancer

February 24, 2023 Medical Communications

Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …

Moda Living and LloydsPharmacy partner to offer residents prescription service

February 24, 2023 Medical Communications

Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP.   VideoGP will …

AstraZeneca signs $63m agreement for gastric cancer treatment

February 23, 2023 Medical Communications

AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …

£1.6bn of research and development funding “surrendered” back to UK Treasury

February 23, 2023 Medical Communications

A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …

FDA approval granted to BD’s HPV assay for use with ThinPrep Pap Test

February 22, 2023 Medical Communications

Becton, Dickinson and Company (BD) has received FDA approval for its new HPV assay which will be used in testing …

Unum UK expands employee digital health app

February 21, 2023 Medical Communications

Employee benefits provider Unum UK has expanded its available modules on its Help@hand app, which aims to provide digital health …

CSL receives CMA from the European Commission for haemophilia B drug

February 21, 2023 Medical Communications

CSL, a biotech company, has announced that it has received conditional marketing authorisation (CMA) from the European Commission (EC) for …
david-travis-avvzjc0ynbq-unsplash

FDA approves Apellis’ geographic atrophy treatment

February 20, 2023 Medical Communications

Apellis’ Syfovre (pegcetacoplan injection) is indicated for patients with geographic atrophy (GA) with or without subfoveal involvement, and has received …

Medtronic’s extravascular defibrillator receives CE mark

February 20, 2023 Medical Communications

Medtronic has received CE mark for its extravascular defibrillator. The Aurora EV-ICD™ MRI SureScan™ and Epsila EV™ MRI SureScan™ defibrillation …

Pfizer’s Lyme disease vaccine study cut due to protocol violations

February 20, 2023 Medical Communications

Valneva and Pfizer have seen their Lyme disease vaccine study cut down after some clinical trial sites were revealed to …

Sun Pharma recalls at least 34,000 bottles of generic drug

February 13, 2023 Medical Communications

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, …

AstraZeneca moves manufacturing to Ireland due to Britain’s tax regime

February 10, 2023 Medical Communications

Big pharma giant, AstraZeneca, has announced that its plans to open a new facility in northwest England have now changed, …

FDA grants full approval to GSK for mismatch repair-deficient endometrial cancer treatment

February 10, 2023 Medical Communications

GSK announced that its treatment for recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer has been granted full approval by …
The Gateway to Local Adoption Series

Latest content